Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.
By A. Levey, R. Atkins, Josef Coresh, E. Cohen, A. Collins, Kai-Uwe Eckardt, M. Nahas, Bertrand L. Jaber, M. Jadoul, A. Levin and 5 more. Kidney International, 2007
1,516 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Nephrology
View Paper: https://www.semanticscholar.org/paper/9a096c3c4efea42082b351a8d0e8b5fa85fa6610
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Nephrology
- D. Rothenbacher
- Qiu-li Zhang
- B. Astor
- Josef Coresh
- Marcello Tonelli
- K. Matsushita
- R. Gansevoort
- G. Curhan
Citations in the corpus
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. (2011, background): “03% of the total population.(28) The economic burden associated with milder forms of CKD is huge: more than twice the total cost of ESRD.”
- Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011, background): “Presently, screening for chronic kidney disease is recommended in people at high risk for chronic kidney disease including patients with cardiovascular disease risk factors.(4) However, the associations between eGFR and albuminuria with mortality may differ in high-risk populations as compared with ”
- An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines (2020, background): “and KDIGO group recommend that all people with diabetes should have renal function and albuminuria measured at diagnosis and annually thereafter in T2DM; in T1DM, this can start from 5 years after diagnosis.(32,48) Albuminuria is best assessed using ACR measurements on spot urine samples (ideally ea”
- Prevalence of chronic kidney disease in population-based studies: Systematic review (2008, background): “However, the differences in the prevalence of comorbidities and/or other factors related to risk of CKD, such as the prevalence of cardiovascular diseases, diabetes, infection, or lifestyle and socioeconomic factors, might affect the prevalence of CKD [74].”
- Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes (2011, methodology): “Available treatments for end-stage renal disease (ESRD) include dialysis and kidney transplantation (1,2).”